CARsgen Therapeutics Holdings Limited is a biopharmaceutical company with operations in China and the U.S. The company focuses on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. CARsgen has developed novel technologies and a product pipeline with global rights to address major challenges of CAR T-cell therapies, such as improving the safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs.
Headquarters
P.O. Box 31119, Grand Pavilion, Hibiscus Way, 802 West Bay Road
George Town; Grand Cayman;
Postal Code: KY1-1205
Contact Details: Purchase the CARsgen Therapeutics Holdings Limited (Hong Kong) (科济药业控股有限公司 (香港)) report to view the information.
Website: http://www.carsgen.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service